Long-term growth of children with nephrogenic diabetes insipidus
- PMID: 18584216
- DOI: 10.1007/s00467-008-0844-8
Long-term growth of children with nephrogenic diabetes insipidus
Abstract
Primary nephrogenic diabetes insipidus (NDI) is a genetic, chronic disease characterised by lack of distal renal tubule to antidiuretic hormone. The condition produces polyuria, polydipsia, and consequently, reduced caloric intake and growth failure. There is very scarce information on physical growth of affected children. The objective of the paper is to describe long-term growth of 14 patients from 11 families, studied retrospectively and followed for 3-16 years (median 11.6 years). Diagnosis was made on the basis of clinical and laboratory data and concentration test under pitressin. Patients were treated with indomethacin, thiazides, and amiloride. Weight and standing height was measured periodically at the Laboratory of Anthropometry, following standardised techniques. Information was obtained from clinical notes. The majority of children grew below the third centile of local standards, and many showed improvement of weight, height, and body mass index (BMI) over time. Mean height, weight, and BMI gain during follow-up was 1.72, 1.06, and 1.46 standard deviations (SDs), respectively. Three children who did not adhere to treatment showed growth delay. Height gain during the first 2 years of follow-up was inversely associated with height deficit at diagnosis. Further studies on growth at adolescence and in different mutations are recommended.
Similar articles
-
Nephrogenic diabetes insipidus presenting with developmental delay and intracranial calcification.Indian J Pediatr. 2005 Jun;72(6):527-8. doi: 10.1007/BF02724433. Indian J Pediatr. 2005. PMID: 15985744
-
Nephrogenic Diabetes Insipidus.Pediatr Clin North Am. 2019 Feb;66(1):227-234. doi: 10.1016/j.pcl.2018.09.006. Pediatr Clin North Am. 2019. PMID: 30454745 Review.
-
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.Eur J Pediatr. 2015 Oct;174(10):1373-85. doi: 10.1007/s00431-015-2534-4. Epub 2015 Apr 23. Eur J Pediatr. 2015. PMID: 25902753
-
Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus.J Am Soc Nephrol. 1999 Sep;10(9):1958-64. doi: 10.1681/ASN.V1091958. J Am Soc Nephrol. 1999. PMID: 10477148
-
V2R mutations and nephrogenic diabetes insipidus.Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7. Prog Mol Biol Transl Sci. 2009. PMID: 20374732 Review.
Cited by
-
Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study.Front Pediatr. 2020 Jan 21;7:550. doi: 10.3389/fped.2019.00550. eCollection 2019. Front Pediatr. 2020. PMID: 32039113 Free PMC article.
-
Clinical and Functional Characterization of a Novel Mutation in AVPR2 Causing Nephrogenic Diabetes Insipidus in a Four-Generation Chinese Family.Front Pediatr. 2021 Dec 9;9:790194. doi: 10.3389/fped.2021.790194. eCollection 2021. Front Pediatr. 2021. PMID: 34956990 Free PMC article.
-
Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease.Nat Rev Nephrol. 2019 Sep;15(9):577-589. doi: 10.1038/s41581-019-0161-4. Epub 2019 Jun 13. Nat Rev Nephrol. 2019. PMID: 31197263 Free PMC article. Review.
-
Novel de novo AVPR2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus.Case Rep Nephrol Dial. 2017 Sep 27;7(3):130-137. doi: 10.1159/000480009. eCollection 2017 Sep-Dec. Case Rep Nephrol Dial. 2017. PMID: 29177155 Free PMC article.
-
CANDID Study: Clinical and Molecular Characterization of Congenital Arginine Vasopressin-Resistance and the Use of a Novel Diagnostic Biomarker in Indian Children.Indian J Pediatr. 2025 Feb 24. doi: 10.1007/s12098-025-05446-5. Online ahead of print. Indian J Pediatr. 2025. PMID: 39992531
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical